7 July 2022

COVID-19

Here comes our third Omicron wave

7 July 2022

osteomyelitis Research Spondyloarthritis

Does MTX background therapy boost placebo response?

7 July 2022

Exercise Mental Health Osteoarthritis

Exercise eases fibromyalgia pain, depression

7 July 2022

Pain Pharmaceuticals

Pharmacist naloxone program extended

6 July 2022

Fibromyalgia Pain Pharmaceuticals

Opioids no better for post-surgical pain

30 June 2022

COVID-19

Best N95 mask for healthcare workers

30 June 2022

Juvenile Arthritis Osteoporosis Spondyloarthritis

Risk from low-dose steroids challenged

30 June 2022

Research

Lancet Rheumatology tops rheum journal impact factor rankings

30 June 2022

Research Surgical

Q&A with Associate Professor Helen Benham

30 June 2022

Complementary Rheumatoid Arthritis

Curcumin for OA: what is the evidence?

23 June 2022

APLAR Osteoporosis

Osteoporosis raises risk of infections

23 June 2022

Analgesics Mental Health Rheumatoid Arthritis

Mental illness leads chronic disease pack

16 June 2022

Comment COVID-19

The end of covid vigilance

16 June 2022

COVID-19 Lupus Scleroderma Spondyloarthritis

Rituximab and non-white ethnicity linked with worse covid outcomes

16 June 2022

PBS Political Rural

New government – what now for rheumatology?

16 June 2022

Analgesics COVID-19

Doctors at risk of green-nail syndrome